Popular on eTradeWire
- Medical Arts Clinic at River Road in Greenwood, MS Welcomes New Tenant Second Chance Healthcare - 1286
- $15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB - 197
- 6th Annual Waco Family & Faith International Film Festival Shines A Spotlight on Indie Filmmakers and Celebrates Its Community - 189
- Countertop Pro GTA Launches Full-Service Kitchen Remodeling in Greater Toronto - 180
- Thrive Leadership Institute Celebrates Black Excellence in East Orange - 146
- New Hampshire Document Shredding Expands Residential & Medical Shredding Services in Nashua New Hampshire - 142
- Behind A Pyramid Lake Story: An Exclusive Interview with the Award-Winning Author - 140
- Emily Oster's ParentData Launches New Content on Trying to Conceive - 135
- NEXS BioMedica Unveils CancerScope-AI: A Game-Changer in Rare Cancer Treatment - 134
- A Love Letter to the Bay: The 18th Annual All-Star Gospel Celebration Draws Capacity Crowd for an Unforgettable Night - 131
Similar on eTradeWire
- Dentaluxe's New Website Launch!
- $300 Million in Milestones Plus Tiered Double-Digit Royalties to License & Distribute NRX-100 Drug: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- MiBA Announces Key Leadership Team Appointment
- Restoration Dental Launches New Website to Enhance Patient Experience
- OneSolution Dental Implant Centers Announces All-on-X Digital Workflow Master Course in Palm Beach, FL
- BSI excited to be chosen to attend Singapore Maritime week & SeaAsia with TMA BlueTech Trade Mission
- Inavya Ventures Ltd Recognized Among the Most Innovative Companies to Watch in 2025 by The CEO Vision
- "National Employer Tax Reduction Month" Launched By HR Advisory Firm Employers HRx
- Milestone Merger Payment with Predictive Oncology to Advance AI-Driven Biomarker Discovery & Precision Medicine in Cancer & Beyond: Stock Symbol: RENB
- $15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB
Mcl-1L Cytoplasmic Domain Human Recombinant
eTradeWire News/10772386
SAN DIEGO - eTradeWire -- Mcl-1L Cytoplasmic Domain Human Recombinant
Mcl-1L Cytoplasmic Domain Human Recombinant is a high quality member of the Bcl-2 family of proteins, which play a key role in regulating apoptosis (programmed cell death) and cell survival. The cytoplasmic domain of Mcl-1L is a specific region of the protein that is involved in its cellular functions. This recombinant protein can be used in research to study the function and regulation of Mcl-1L, as well as its interactions with other proteins involved in cell survival and apoptosis. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Mcl-1L Cytoplasmic Domain Human Recombinant
Catalog number: B2016818
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 µg
More on eTradeWire News
Molecular Weight or Concentration: 36 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: Bcl-2-like Protein 3, EAT/Mcl-1, Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1, Mcl-1 Long Isoform
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Kim JH, Bae J. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis PLoS One. 2013 Nov 18;8(11):e79626.
2: Fukumoto T, Iwasaki T, Okada T, Hashimoto T, Moon Y, Sakaguchi M, Fukami Y, Nishigori C, Oka M. High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis Genes Cells. 2016 Feb;21(2):185-99.
https://moleculardepot.com/product/mcl-1l-cytoplasmic-domain-human-recombinant/
Mcl-1L Cytoplasmic Domain Human Recombinant is a high quality member of the Bcl-2 family of proteins, which play a key role in regulating apoptosis (programmed cell death) and cell survival. The cytoplasmic domain of Mcl-1L is a specific region of the protein that is involved in its cellular functions. This recombinant protein can be used in research to study the function and regulation of Mcl-1L, as well as its interactions with other proteins involved in cell survival and apoptosis. This product has been used as a molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.
Mcl-1L Cytoplasmic Domain Human Recombinant
Catalog number: B2016818
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 50 µg
More on eTradeWire News
- Beverly Peyton has been endorsed for Bartow County Georgia GOP Chair by Veterans for America First
- Urbanate: Bridging the Equity Gap for Real Estate Developers with Global Investment Opportunities
- CSArts-SGV Popular Music Conservatory Hosts Benefit Concert for Fire Relief
- City of Sanger Police Department Partners with Education Foundation and ISD to launch the Blue Santa Program to Support Local Students in Need
- Neurobit's AI-Powered Medical Devices Bridge the Diagnostic Gap in Dizziness and Vertigo
Molecular Weight or Concentration: 36 kDa
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: Bcl-2-like Protein 3, EAT/Mcl-1, Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1, Mcl-1 Long Isoform
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.
References:
1: Kim JH, Bae J. MCL-1ES induces MCL-1L-dependent BAX- and BAK-independent mitochondrial apoptosis PLoS One. 2013 Nov 18;8(11):e79626.
2: Fukumoto T, Iwasaki T, Okada T, Hashimoto T, Moon Y, Sakaguchi M, Fukami Y, Nishigori C, Oka M. High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis Genes Cells. 2016 Feb;21(2):185-99.
https://moleculardepot.com/product/mcl-1l-cytoplasmic-domain-human-recombinant/
Source: Molecular Depot
Filed Under: Biotech
0 Comments
Latest on eTradeWire News
- SOFT OPENING FRIDAY - Bavarian Inn Unveils Bavarian Blast Waterpark
- Harbour Trust welcomes a new Portfolio Manager to the team
- Living Water Mental Health BRAIN Treatment Center Offers Breakthrough TMS Therapy
- Affordable Marketing Solutions in Lake County, FL
- Doc Norton & Associates Launches Collaboration Contracts Beta
- CAL Business Solutions Makes Strategic Investment in Growth with Appointment of Ken Gauld as ERP Sales Consultant
- SB Real Estate Partners Acquire Las Vegas Apartment Community for $42 Million
- Origins and Crossroads Poetry Reading Honors Harriet Tubman
- Hunters Run Fitness Challenge: A Step Forward In Employee Wellness
- Why Every Photographer Should Have Access to a Professional Photo Studio
- Valley Sleep Center Welcomes Dr. Sarah Cordova Kuper to the Team
- Tile and Stone Source: Premium Tiles & Natural Stone for Every Project in Alberta
- Reliable, High-Performance Sealing with CBS SYMS Sealer
- Dentaluxe's New Website Launch!
- VensureHR and American Association Announce Extension of Partnership
- PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs
- Inaugural Palm Beach Gala for Fallen Patriots – Hosted by CBIZ Raises Over $2.4 Million
- Benjamin Ross Group, LLC Sells Professional Service Business, New Jersey
- Stratfield Consulting Welcomes Bill Boucher as Executive Director - Growth
- Cambridge School of Culinary Arts To Expand Online Cooking Class Offerings with Four New Courses